Open Access

Mini-bronchoalveolar lavage fluid can be used for biomarker identification in patients with lung injury by employing 1H NMR spectroscopy

Critical Care201317:430

https://doi.org/10.1186/cc12607

Published: 24 April 2013

Acute respiratory distress syndrome (ARDS) is a serious lung injury and has low survival rates. More than 150,000 cases of ARDS are diagnosed every year in the US alone, according to the National Heart, Lung, and Blood Institute database. 1H nuclear magnetic resonance (NMR) has been a well-established technique for the recognition of biomarkers in various body fluids [1]. Over last few decades, investigators have searched for novel biomarkers for the diagnosis and prognosis of patients with lung injury [2]. Bronchoalveolar lavage (BAL) fluid has been used for years for diagnosis and prognosis of lung injury and related pulmonary diseases by means of various techniques [2]. BAL fluid is favored over mini-bronchoalveolar lavage (mBAL) for diagnostic as well as research purposes since the former is extracted from the immediate vicinity of alveoli. mBAL requires that fluid be taken from proximal alveoli and bronchi but can provide information about biochemical events happening inside the lungs. In this letter, we show, via 1H NMR spectroscopy, that small metabolites present in BAL fluid and mBAL fluid are similar and can be used for metabolomics-related studies [3]. NMR spectroscopy of BAL has been used for metabolomic analysis of cystic fibrosis [4]. 1H NMR spectroscopy of mBAL fluid can be used for other prospective studies such as those that are conducted to differentiate between infective (pulmonary) and inflammatory (non-pulmonary) ARDS and to determine the type of microbial infection associated with them [5, 6]. Though extracted from a different location, mBAL fluid has small metabolites similar to those of BAL fluid. This is shown in Figures 1a and 1b, which depict one-dimensional and two-dimensional NMR spectra of BAL fluid and mBAL fluid, which are represented by red and black colors, respectively. Qualitatively, only choline metabolite, which is present in mBAL fluid and absent in BAL fluid, is different. Quantitatively, most of the metabolite resonances had similar intensities. In a recently published article, we showed that by combining 1H NMR spectroscopy of mBAL fluid with multivariate statistical analysis, we can clearly differentiate between patients with lung injury and healthy controls [7]. In this first report of 1H NMR of mBAL fluid, we showed an association of small metabolites with severity of infection. Taurine and threonine levels were found to be elevated in cases of ARDS, and have been correlated to severity of infection earlier. Additionally, concentrations of leucine, valine and isoleucine (muscle breakdown products), arginine, glycine, aspartic acid, succinate, acetate, and glutamate were elevated and proline level was found to be decreased in cases of ARDS. Hence, on the basis of our results, we conclude that mBAL fluid combined with 1H NMR spectroscopy can be used for diagnosis and prognosis of ARDS and its severity.
Figure 1

One-dimensional (a) and two-dimensional (b) 1 H nuclear magnetic resonance spectrum of bronchoalveolar lavage fluid (BALF) (red) and mini-BALF (mBALF) (black). Peaks corresponding to various small molecular weight metabolites were identified and are shown in the figure. ppm, parts per million.

Abbreviations

ARDS: 

acute respiratory distress syndrome

BAL: 

bronchoalveolar lavage

mBAL: 

mini-bronchoalveolar lavage

NMR: 

nuclear magnetic resonance.

Declarations

Acknowledgements

CS and RKR acknowledge the Council for Scientific and Industrial Research (New Delhi, India) for research fellowship. NS acknowledges the Department of Biotechnology (New Delhi, India).

Authors’ Affiliations

(1)
Centre of Biomedical Magnetic Resonance, Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS) - Campus
(2)
Critical Care Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences

References

  1. Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC, Nicholson JK: Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2007, 2: 2692-2703. 10.1038/nprot.2007.376View ArticlePubMedGoogle Scholar
  2. Cribbs SK, Martin GS: Biomarkers in acute lung injury: are we making progress? Crit Care Med 2008, 36: 2457-2459. 10.1097/CCM.0b013e318181052aPubMed CentralView ArticlePubMedGoogle Scholar
  3. Emmanuel B, Dominique B, Sarah D, Christian G, Thomas R, Jean-Baptiste G, Fabien X, Marie-Claude S, Bernard A: Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients. Intensive Care Med 2007, 33: 1519-1523. 10.1007/s00134-007-0688-xView ArticleGoogle Scholar
  4. Wolak JE, Esther CR Jr, O'Connell TM: Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients. Biomarkers 2009, 14: 55-60. 10.1080/13547500802688194View ArticlePubMedGoogle Scholar
  5. Gupta A, Bansal N, Houston B: Metabolomics of urinary tract infection: a new uroscope in town. Expert Rev Mol Diagn 2012, 12: 361-369. 10.1586/erm.12.27View ArticlePubMedGoogle Scholar
  6. Nicholson JK, Wilson ID: Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2003, 2: 668-676. 10.1038/nrd1157View ArticlePubMedGoogle Scholar
  7. Rai RK, Azim A, Sinha N, Sahoo JN, Singh C, Ahmed A, Saigal S, Baronia AK, Gupta D, Gurjar M, Poddar B, Singh RK: Metabolic profiling in human lung injuries by high-resolution nuclear magnetic resonance spectroscopy of bronchoalveolar lavage fluid (BALF). Metabolomics 2012, 1-10. doi:10.1007/s11306-012-0472-yGoogle Scholar

Copyright

© BioMed Central Ltd 2013

Advertisement